Coherus Bio (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -209,409 | -238,286 | -127,788 | -223,938 | -87,177 |
| Depreciation Amortization | 3,235 | 3,398 | 2,996 | 1,869 | 674 |
| Accounts receivable | N/A | 1,859 | -299 | 2,710 | -3,954 |
| Accounts payable and accrued liabilities | -534 | -4,454 | -7,636 | 19,932 | 5,266 |
| Other Working Capital | 10,297 | -5,133 | -159,214 | 91,115 | 28,434 |
| Other Operating Activity | 37,145 | 42,330 | 39,396 | 322 | 32,830 |
| Operating Cash Flow | $-159,266 | $-200,286 | $-252,545 | $-107,990 | $-23,927 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -789 | -4,573 | -6,515 | -6,164 | -2,849 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 2,334 |
| Purchase Of Investment | -42,869 | -74,344 | N/A | N/A | N/A |
| Sale Of Investment | 43,170 | 74,500 | N/A | N/A | N/A |
| Other Investing Activity | -700 | 0 | 0 | -785 | -10 |
| Investing Cash Flow | $-1,188 | $-4,417 | $-6,515 | $-6,949 | $-525 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 100,000 | N/A | N/A |
| Common Stock Issued | 103,830 | 482 | 126,918 | 1,429 | 85,474 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -2 |
| Other Financing Activity | 1,591 | 206,305 | -739 | 121,260 | 50,484 |
| Financing Cash Flow | $105,421 | $206,787 | $226,179 | $122,689 | $135,956 |
| Exchange Rate Effect | 468 | -120 | -398 | 84 | -666 |
| Beginning Cash Position | 127,756 | 125,792 | 159,071 | 150,392 | 39,554 |
| End Cash Position | 73,191 | 127,756 | 125,792 | 158,226 | 150,392 |
| Net Cash Flow | $-54,565 | $1,964 | $-33,279 | $7,834 | $110,838 |
| Free Cash Flow | |||||
| Operating Cash Flow | -159,266 | -200,286 | -252,545 | -107,990 | -23,927 |
| Capital Expenditure | -789 | -4,573 | -6,515 | -6,164 | -2,849 |
| Free Cash Flow | -160,055 | -204,859 | -259,060 | -114,154 | -26,776 |